These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 11377549

  • 21. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
    McDiarmid S, Goss J, Seu P, Shackleton C, Vargas J, Ament M, Busuttil R.
    Transplant Proc; 1998 Jun; 30(4):1397-8. PubMed ID: 9636564
    [No Abstract] [Full Text] [Related]

  • 22. ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
    Kumar MS, Cahill K, Kumar AM, Panigrahi D, Seirka D, Singleton R, al-Abdullah IH, Laskow DA.
    Transplant Proc; 1998 Jun; 30(4):1351-2. PubMed ID: 9636549
    [No Abstract] [Full Text] [Related]

  • 23. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C.
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.
    Ann Transplant; 2000 May; 5(1):43-6. PubMed ID: 10850611
    [Abstract] [Full Text] [Related]

  • 25. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW.
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.
    Maggi U, Rossi G, Vannelli A, Caccamo L, Gatti S, Paone G, Reggiani P, Melada E, Latham L, Andreani P, Fassati LR.
    Transplant Proc; 1998 Dec; 30(8):3946-7. PubMed ID: 9865255
    [No Abstract] [Full Text] [Related]

  • 27. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM, Kormos RL, Kawai A, Murali S, Hattler BG, Demetris AJ, Griffith BP.
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract] [Full Text] [Related]

  • 28. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.
    Miller J, Pirsch JD, Deierhoi M, Vincenti F, Filo RS.
    Transplant Proc; 1997 Apr; 29(1-2):304-5. PubMed ID: 9123008
    [No Abstract] [Full Text] [Related]

  • 29. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
    Lemmens HP, Langrehr JM, Blumhardt G, Lohmann R, Knoop M, Verschl J, Schattenfroh N, Neuhaus R, Hopf U, Bechstein WO.
    Transplant Proc; 1994 Dec; 26(6):3622-3. PubMed ID: 7527983
    [No Abstract] [Full Text] [Related]

  • 30. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS, Newell KA, Woodle ES, Millis JM, Piper JB, Huss E, Thistlethwaite JR.
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract] [Full Text] [Related]

  • 31. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K, Munn SR, Sterioff S.
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract] [Full Text] [Related]

  • 32. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P.
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract] [Full Text] [Related]

  • 33. Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
    Samuel D, Bismuth H, Boillot O, Ducerf C, Baulieux J, Gugenheim J, Baldini E, Launois B, Messner M, Wolf P, Ellero E, Domergue J, Pageaux J, Cherqui D, Duvoux C, Durand F, Belghiti J, Calmus Y, Massault PP, Neau-Cransac M, Saric J, LeTreut Y, Campan P.
    Transplant Proc; 1998 Jun; 30(4):1394-6. PubMed ID: 9636563
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparative efficacy of prophylactic monoclonal (OKT3) and polyclonal antibodies (ATG) in immunologic high-risk renal transplant recipients.
    Fukuuchi F, Lefrançois N, Chapuis F, Gebuhrer L, Bosshard S, Dubernard JM, Touraine JL.
    Transplant Proc; 1996 Oct; 28(5):2808-9. PubMed ID: 8908070
    [No Abstract] [Full Text] [Related]

  • 36. Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.
    Rafecas A, Lladó L, Albiol MT, Ramos E, Torras J, Fabregat J, Lama C, Busquets J, Ibáñez L, Figueras J, Jaurrieta E.
    Transplant Proc; 2002 Feb; 34(1):107. PubMed ID: 11959209
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Combined liver-kidney transplantation: long-term follow-up in 18 patients.
    Lang M, Kahl A, Bechstein WO, Neumann U, Settmacher U, Frei U, Neuhaus P.
    Transplant Proc; 1998 Aug; 30(5):1865-7. PubMed ID: 9723313
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Neoral is superior to FK 506 in liver transplantation.
    Levy GA.
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.